Evidence map›Paper›PMID 42678900›Full record

ArticleHormone research in paediatrics2026

Adrenal Androgens, Estrone, and Insulin-Like Growth Factor 1 Are Associated with Thelarche without Gonadotropin Activation in Girls.

Saija Burtsov, Anna Viitasalo, Sonja Soininen, Merja R Häkkinen, Seppo Auriola, Aino Mäntyselkä, Raimo Voutilainen, Jarmo Jääskeläinen, Timo A Lakka

Abstract read
In one paragraph

Article in Hormone research in paediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Saija BurtsovInstitute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland, ssavinai@uef.fi.
Anna ViitasaloInstitute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Sonja SoininenInstitute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Merja R HäkkinenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Kuopio, Finland.
Seppo AuriolaSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Aino MäntyselkäDepartment of Pediatrics, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland.
Raimo VoutilainenDepartment of Pediatrics, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland.
Jarmo JääskeläinenDepartment of Pediatrics, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland.
Timo A LakkaInstitute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough a well-known phenomenon, the hormonal mechanism of thelarche in the absence of gonadotropin activation remains unclear. To reveal the biological mechanisms of such thelarche, we assessed serum concentrations of several hormones potentially related to breast development, as well as clinical signs of androgen action.

methodsA population-based sample of 175 girls aged 9-11 was divided into those without thelarche (Tanner breast stage 1) and those with thelarche (Tanner breast stage ≥2). The girls were further categorized based on basal serum luteinizing hormone (LH) using a cut-off of 0.3 IU/L. This resulted in three groups: 114 girls with low LH without thelarche, 32 girls with low LH and thelarche, and 29 girls with higher LH and thelarche. Serum concentrations of sex steroids and insulin-like growth factor-1 (IGF-1) and clinical signs of androgen action were assessed at ages 7-9 and 9-11 years.

resultsGirls with low LH and thelarche had higher levels of dehydroepiandrosterone sulfate (DHEAS) (0.80 vs. 0.60 µmol/L, p = 0.03 at 7-9 years; 0.97 vs. 0.72 µmol/L, p = 0.03 at 9-11 years), testosterone (0.18 vs. 0.14 nmol/L, p = 0.02; 0.27 vs. 0.22 nmol/L, p = 0.02), estrone (14.5 vs. 11.5 pmol/L, p = 0.02; 24.3 vs. 18.2 pmol/L, p = 0.002), and IGF-1 (28.6 vs. 23.6 nmol/L, p = 0.001; 35.9 vs. 31.1 nmol/L, p = 0.006) than girls with low LH without thelarche. Differences in DHEAS, testosterone, and IGF-1 diminished after further adjustment for body fat percentage. Girls with low LH and thelarche also had more clinical signs of androgen action at both ages than girls with low LH without thelarche. There were no statistically significant differences in hormonal concentrations at 7-9 years between girls with low LH and thelarche and those with higher LH and thelarche. However, at 7-9 years, girls with low LH and thelarche had more signs of androgen action than girls with higher LH and thelarche. At 9-11 years, girls with higher LH and thelarche had higher hormonal concentrations except for DHEAS than girls with low LH and thelarche.

conclusionThelarche with low LH is associated with elevated DHEAS, testosterone, estrone, and IGF-1 concentrations, which is partly explained by BF%, suggesting that aromatization of adrenal androgens to estrogens in adipose tissue is one hormonal mechanism of thelarche in girls without gonadotropin activation.

Indexed as

Adrenal androgensAdrenarcheIsolated thelarcheSex steroidsThelarche

Identifiers

PMID42678900
PMCPMC13685405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.